Location History:
- Bari, IT (2012)
- Potenza, IT (2018)
Company Filing History:
2 out of 17 
1 out of 1 
1 out of 3 Years Active: 2012-2018
Title: Monica Carmosino: Innovator in Nephrogenic Diabetes Insipidus Treatment
Introduction
Monica Carmosino is a notable inventor based in Potenza, Italy. She has made significant contributions to the field of medicine, particularly in the treatment of nephrogenic diabetes insipidus. With a total of two patents to her name, her work focuses on innovative therapeutic approaches.
Latest Patents
Monica's latest patents include "Selective agonists of beta-adrenergic type 3 receptors (BAR3) and use thereof." This invention aims to utilize selective agonists of beta-adrenergic type 3 receptors in the treatment of nephrogenic diabetes insipidus, especially X-linked nephrogenic diabetes insipidus. Another patent is titled "Method of treatment of nephrogenic diabetes insipidus," which proposes the use of statins as a treatment method for this condition.
Career Highlights
Throughout her career, Monica has worked with esteemed institutions such as Università Degli Studi Di Bari and Università Degli Studi Della Basilicata. Her research has been pivotal in advancing the understanding and treatment of nephrogenic diabetes insipidus.
Collaborations
Monica has collaborated with notable colleagues, including Maria Svelto and Giuseppe Procino, contributing to her innovative research and development efforts.
Conclusion
Monica Carmosino's work exemplifies the impact of innovation in medical treatments, particularly for nephrogenic diabetes insipidus. Her patents reflect her dedication to improving patient care through scientific advancements.